Virologists are specialized microbiologists who investigate the structure, genetics, replication, and behavior of viruses such as influenza, HIV, SARS-CoV-2, hepatitis, and emerging zoonotic pathogens. Day to day, they culture viruses in biosafety-rated laboratories, sequence viral genomes, run molecular and immunological assays, analyze data, write grant proposals, and publish findings. Many also track outbreaks, advise public health agencies, and collaborate with epidemiologists, clinicians, and bioinformaticians.
The work spans academia, government agencies (CDC, NIH, USDA, FDA), biotechnology and pharmaceutical companies, hospitals, and diagnostic laboratories. Virologists contribute directly to vaccine design, antiviral drug discovery, diagnostic test development, and pandemic preparedness. The career demands patience, rigorous lab discipline, and a long educational path, but offers the chance to work on problems with enormous global health impact.
| Entry level | $58,000 |
| Median | $98,000 |
| Senior | $145,000 |
| Top 10% | $190,000 |
| Job growth | +9% |
| Professionals in the USA | 0.02 million |
| Typical hours/week | 44 hrs |
| Remote work share | 8% |
| Annual job openings | 2,500/yr |
| Demand | 4.4 / 10 (Moderate) |
AI is accelerating virology research through protein structure prediction, genomic sequence analysis, and viral evolution modeling. Tools like AlphaFold and machine learning-based surveillance systems are augmenting rather than replacing virologists, who remain essential for experimental design, wet-lab work, and scientific interpretation.
Automation exposure: AI can automate large-scale sequence alignment, phylogenetic analysis, literature reviews, image analysis of cell cultures and microscopy, drug candidate screening, and routine data processing. Lab robotics can also handle high-throughput assay workflows.
The human edge: Virologists bring hypothesis generation, creative experimental design, hands-on biosafety-level lab skills, ethical judgment around dual-use research, and the ability to interpret ambiguous biological results. Communicating findings to policymakers and the public during outbreaks also requires human trust and credibility.
Figures are estimates for exploration — verify current data with BLS.gov.